For Publishers
DiscoveryMetadataPeer reviewHostingPublishing
For Researchers
JoinPublishReviewCollect
Register
Blog
About
Search
Advanced search
My ScienceOpen
Search
For Publishers
For Researchers
Blog
About
1
views
20
references
 Top references
cited by
1
    
0 reviews
 Review
0
comments
 Comment
0
recommends
+1 Recommend
0 collections
    0
    shares
      223
      similar
       All similar
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Use of 18F‐2‐deoxy‐2‐fluoro‐D‐glucose positron emission tomography/computed tomography for staging thyroid carcinoma in a cat

      case-report

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Thyroid nodules are common in older cats and are mostly benign; however, carcinomas may occur infrequently. In cats, thyroid carcinomas tend to be highly metastatic. The role of 18F‐2‐deoxy‐2‐fluoro‐D‐glucose (FDG) positron emission tomography (PET)/computed tomography (CT) in human thyroid carcinoma has been well established. However, guidelines have not yet been established for veterinary medicine. Metastasis assessment has typically been performed using CT in veterinary medicine; however, it is poorly sensitive in detecting regional lymph nodes or distant metastases if these lesions are not abnormally contrast‐enhanced, enlarged or cause overt mass effects. This case suggested that FDG PET/CT may be used for staging feline thyroid carcinoma, and the results contributed to treatment recommendations.

          Abstract

          The role of 18F‐2‐deoxy‐2‐fluoro‐D‐glucose (FDG) positron emission tomography (PET)/computed tomography (CT) in human thyroid carcinoma has been well established. However, guidelines have not yet been established for veterinary medicine. This case suggested that FDG PET/CT may be used for staging feline thyroid carcinoma, and the results contributed to treatment recommendations.

          Related collections

          Most cited references20

          • Record: found
          • Abstract: found
          • Article: not found

          Clinical applications of PET in oncology.

          Eric Rohren, Timothy Turkington, Denis Coleman (2004)
          Positron emission tomography (PET) provides metabolic information that has been documented to be useful in patient care. The properties of positron decay permit accurate imaging of the distribution of positron-emitting radiopharmaceuticals. The wide array of positron-emitting radiopharmaceuticals has been used to characterize multiple physiologic and pathologic states. PET is used for characterizing brain disorders such as Alzheimer disease and epilepsy and cardiac disorders such as coronary artery disease and myocardial viability. The neurologic and cardiac applications of PET are not covered in this review. The major utilization of PET clinically is in oncology and consists of imaging the distribution of fluorine 18 fluorodeoxyglucose (FDG). FDG, an analogue of glucose, accumulates in most tumors in a greater amount than it does in normal tissue. FDG PET is being used in diagnosis and follow-up of several malignancies, and the list of articles supporting its use continues to grow. In this review, the physics and instrumentation aspects of PET are described. Many of the clinical applications in oncology are mature and readily covered by third-party payers. Other applications are being used clinically but have not been as carefully evaluated in the literature, and these applications may not be covered by third-party payers. The developing applications of PET are included in this review.
          Article 0 comments Cited 105 times – based on 0 reviews     Review now
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            The implication of lymph node metastasis on survival in patients with well-differentiated thyroid cancer.

            Joshua D I Ellenhorn, Yale D Podnos, David Smith … (2005)
            Though survival for well-differentiated thyroid cancer is very good, specific populations suffer greater recurrence and mortality. Defining these cohorts can significantly influence prognosis and extent of treatment. This study, using a large, multi-institutional database, seeks to determine how the presence of lymph node disease in patients with well-differentiated thyroid cancer affects outcome. The Surveillance, Epidemiology, and End Results (SEER) database is a large-scale sample of 14 per cent of the U.S. population. It was used to identify patients with papillary and follicular thyroid carcinomas and identify the prognostic implications of lymph node metastasis. Additional factors, including presence of metastasis, age, and tumor size, were compared using multivariate and chi2 analyses. Of 19,918 patients identified, lymph node status was known for 9,904 (49.7%). On multivariate analysis, age > 45 years, presence of distant metastasis, large tumor size, and lymph node involvement significantly predicted poor outcome. Overall survival at 14 years was 82 per cent for node negative and 79 per cent for node positive patients (P < 0.05). This study shows that the survival of patients with well-differentiated thyroid cancer is adversely affected by lymph node metastases. The optimum treatment for this cohort needs further delineation, as particular populations are at greater risk of recurrence and death.
            Article 0 comments Cited 103 times – based on 0 reviews     Review now
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Changes in clinical and laboratory findings in cats with hyperthyroidism from 1983 to 1993.

              J D Broussard, M Peterson, P R Fox (1995)
              Article 0 comments Cited 23 times – based on 0 reviews     Review now
                Bookmark
                All references

                Author and article information

                Contributors
                Byeong‐Teck Kang:
                ORCID: https://orcid.org/0000-0002-4471-4342
                kangbt@chungbuk.ac.kr
                Journal
                Journal ID (nlm-ta): Vet Med Sci
                Journal ID (iso-abbrev): Vet Med Sci
                Journal ID (doi): 10.1002/(ISSN)2053-1095
                Journal ID (publisher-id): VMS3
                Title: Veterinary Medicine and Science
                Publisher: John Wiley and Sons Inc. (Hoboken )
                ISSN (Electronic): 2053-1095
                Publication date (Electronic): 13 March 2023
                Publication date Collection: May 2023
                Volume: 9
                Issue: 3 ( doiID: 10.1002/vms3.v9.3 )
                Pages: 1026-1030
                Affiliations
                [ 1 ] Laboratory of Veterinary Internal Medicine College of Veterinary Medicine, Chungbuk National University Cheongju Republic of Korea
                Author notes
                [*] [* ] Correspondence

                Byeong‐Teck Kang, Laboratory of Veterinary Internal Medicine, College of Veterinary Medicine, Chungbuk National University, Cheongju, Chungbuk 28644, Republic of Korea.

                Email: kangbt@ 123456chungbuk.ac.kr

                Author information
                https://orcid.org/0000-0002-0351-1477
                https://orcid.org/0000-0002-3810-4193
                https://orcid.org/0000-0003-1372-4430
                https://orcid.org/0000-0002-9816-6900
                https://orcid.org/0000-0001-7162-9592
                https://orcid.org/0000-0002-8882-2329
                https://orcid.org/0000-0002-8043-0152
                https://orcid.org/0000-0002-4471-4342
                Article
                Publisher ID: VMS31106
                DOI: 10.1002/vms3.1106
                PMC ID: 10188059
                PubMed ID: 36913242
                SO-VID: c33b4095-0b23-4cc7-8c92-f2a1958636ef
                Copyright © © 2023 The Authors. Veterinary Medicine and Science published by John Wiley & Sons Ltd.
                License:

                This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.

                History
                Date revision received : 24 January 2023
                Date received : 19 July 2022
                Date accepted : 06 February 2023
                Page count
                Figures: 4, Tables: 0, Pages: 5, Words: 3101
                Funding
                Funded by: Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries , doi 10.13039/501100003668;
                Award ID: 322095‐04
                Categories
                Subject: Case Report
                Subject: CATS
                Subject: Case Reports
                Custom metadata
                source-schema-version-number 2.0
                cover-date May 2023
                details-of-publishers-convertor Converter:WILEY_ML3GV2_TO_JATSPMC version:6.2.8 mode:remove_FC converted:16.05.2023

                Keywords: cat,fdg pet/ct,thyroid carcinoma
                Data availability:
                Keywords: cat, fdg pet/ct, thyroid carcinoma

                Comments

                Comment on this article

                scite_

                Similar content223

                See all similar

                Cited by1

                See all cited by

                Most referenced authors179

                See all reference authors